切换至 "中华医学电子期刊资源库"

中华胸部外科电子杂志 ›› 2023, Vol. 10 ›› Issue (01) : 1 -6. doi: 10.3877/cma.j.issn.2095-8773.2023.01.01

纵隔专题

半胸腺切除术在早期胸腺肿瘤和良性病变中的初步探索
郭松源1, 于丰浩1, 谷志涛1, 茅腾1, 方文涛1,()   
  1. 1. 200030 上海,上海交通大学附属胸科医院胸外科
  • 收稿日期:2022-08-11 修回日期:2022-11-10 接受日期:2022-12-08 出版日期:2023-02-28
  • 通信作者: 方文涛

Hemi-thymectomy as a new approach to early-stage thymic epithelial tumors and benign thymic lesions

Songyuan Guo1, Fenghao Yu1, Zhitao Gu1, Teng Mao1, Wentao Fang1,()   

  1. 1. Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai 200030, China
  • Received:2022-08-11 Revised:2022-11-10 Accepted:2022-12-08 Published:2023-02-28
  • Corresponding author: Wentao Fang
引用本文:

郭松源, 于丰浩, 谷志涛, 茅腾, 方文涛. 半胸腺切除术在早期胸腺肿瘤和良性病变中的初步探索[J]. 中华胸部外科电子杂志, 2023, 10(01): 1-6.

Songyuan Guo, Fenghao Yu, Zhitao Gu, Teng Mao, Wentao Fang. Hemi-thymectomy as a new approach to early-stage thymic epithelial tumors and benign thymic lesions[J]. Chinese Journal of Thoracic Surgery(Electronic Edition), 2023, 10(01): 1-6.

目的

对于早期的胸腺肿瘤,倡导部分胸腺切除或者肿瘤切除的声音一直存在。半胸腺切除的概念基于胸腺的解剖基础,此切除范围位于一侧胸腺的早期胸腺瘤或良性胸腺病灶中。现描述该手术方案的早期术后结果和短期随访结果。

方法

在12个月的时间内,共31名患者接受微创半胸腺切除术,汇总并简述所有患者的临床特征、合并症、术后结果、病理结果以及短期随访结果。

结果

所有患者接受了微创下的半胸腺切除术。其中男11例,女20例;年龄平均52.7(35~77)岁。26例患者有不同程度的合并症,其中12例伴超重,9例伴高血压,3例伴糖尿病,1例伴白细胞减少,1例伴子宫内膜间质肉瘤。31台前外侧入路半胸腺切除术均进展顺利,手术时间平均为60.83(31~91)min,术中失血量平均为49.5(20~200)mL,无术中不良事件和术后短期并发症,围手术期的死亡为0。术后平均住院时间为1.3(1~2) d,术后第1天平均引流量为77.8(0~350) mL,术后胸腔引流管平均留置时间为0.7(0~2) d,10例患者在手术当天拔除胸腔引流管。根据国际抗癌联盟(UICC)的TNM病理分期,术后病理结果显示21例为胸腺瘤(均为T1aN0M0),7例为畸胎瘤,3例为血管瘤,随访6~12个月并没有复发的病例。

结论

基于胸腺解剖的新的胸腺切除范围——半胸腺切除术用于治疗位于一侧胸腺的早期、不伴有重症肌无力且胸腺上皮来源的肿瘤以及良性病变,是一种安全有效的切除方式,有较好的围手术期结果和短期肿瘤学结果。与传统的全胸腺切除相比,理论上半胸腺切除可为部分患者提供更快、更安全的手术体验。

Objective

For early-stage thymic epithelial tumors (TETs) , advocation for partial thymectomy or even thymomectomy has always existed. The concept of hemi-thymectomy is based on the anatomical structure of the thymus; and it is devised to be applied to early-stage TETs and benign thymic lesions located entirely on one lobe of the thymus. This article summarized our preliminary experience with this novel surgical extent including both peri-operative outcomes and short-term prognosis.

Methods

Over a 12-month period, a total of 31 patients underwent minimally invasive hemi-thymectomy. The clinical characteristics, co-morbidities, peri-operative results, final pathology and short-term prognosis of these patients were summarized.

Results

A total of 11 males and 20 females with a mean age of 52.7 (35–77) years underwent minimally invasive hemi-thymectomy for their anterior mediastinal lesions. Twenty-six of them had various degrees of co-morbidities: 12 with overweight, 9 with hypertension, 3 with diabetes mellitus, 1 with leukopenia and 1 with endometrial stromal sarcoma. All 31 hemi-thymectomies via the anterolateral minimally invasive approach were successful without intra-operative adverse events. The mean operation time was 60.83 (31–91) min. The mean intra-operative blood loss was 49.5 (20–200) mL. There were no deaths in peri-operative period. The mean post-operative hospital stay was 1.3 (1–2) days; the mean drainage volume on the first post-operative day was 77.8 (0–350) mL. The mean chest drainage tube indwelling time was 0.7 (0–2) days. Drainage tubes of 10 patients were removed within 24 hours after the surgery. The pathology results showed 21 thymomas, 7 teratomas and 3 hemangiomas. All 21 thymomas were UICC pT1aN0M0. No recurrence was observed during the follow-up (6–12 months) .

Conclusions

Hemithymectomy, a new range of thymectomy based on thymic anatomy, is used to treat early-stage, non-myasthenia gravis-derived tumors of thymic epithelial origin and benign lesions located in one thymus. Preliminary exploration suggests that this is a safe and effective resection method with good perioperative and short-term oncological outcomes. In theory, hemithymectomy has inherent advantages over traditional total thymectomy, and can provide a faster and safer surgical experience for a selected group of patients.

图1 正中胸骨后解剖示意图。胸腺位于前纵隔、两肺之间,包裹在纵隔胸膜内的蝴蝶型器官,左右半胸腺之间有纤维间隔,在术中以此为分界。红色虚线为半胸腺切除术(右半胸腺)的切除范围,胸腺后方为上腔静脉(SVC)和左侧无名静脉(LIV),后下方为心包(pericardium),左右侧为两侧纵隔胸膜和肺组织
图2 右侧半胸腺切除后胸腔镜下所见。术中应完整暴露膈神经(phrenic n.),残留的左半胸腺(Lt lobe)位于心包及腔静脉和左无名静脉的前方,同时术中应避免损伤对侧纵隔胸膜(Lt pleura)
图3 完成切除的左侧半胸腺,使用丝线标注肿物所在位置和方向。背景使用ITMIG会议发放的纵隔背景板面
表1 31名患者的基线数据表
表2 31名患者的术后病理、分型以及分期
1
中国医师协会肿瘤多学科诊疗专业委员会.中国胸腺上皮肿瘤临床诊疗指南(2021版)[J].中华肿瘤杂志202143(4):395-404.
2
Scorsetti MLeo FTrama A,et al.Thymoma and thymic carcinomas[J].Crit Rev Oncol Hematol201699:332-350.
3
Gu ZFu JShen Y,et al.Thymectomy versus tumor resection for early-stage thymic malignancies: a Chinese Alliance for Research in Thymomas retrospective database analysis[J].J Thorac Dis20168(4):680-686.
4
Detterbeck FCZeeshan A.Thymoma: current diagnosis and treatment[J].Chin Med J (Engl)2013126(11):2186-2191.
5
Cao MWang QYin H,et al.Short-term analysis of uniport video-assisted thoracoscopic surgery via the subxiphoid approach without chest tube drainage for anterior mediastinal tumors: a comparative retrospective study[J].Ann Transl Med20219(22):1687.
6
Zhang LLi MJiang F,et al.Subxiphoid versus lateral intercostal approaches thoracoscopic thymectomy for non-myasthenic early-stage thymoma: A propensity score -matched analysis[J].Int J Surg201967:13-17.
7
Xu HLiu DLi Y,et al.The Outcomes of Subxiphoid Thoracoscopic Versus Video-Assisted Thoracic Surgery for Thymic Diseases[J].J Laparoendosc Adv Surg Tech A202030(5):508-513.
8
Narm KSLee CYDo YW,et al.Limited thymectomy as a potential alternative treatment option for early-stage thymoma: A multi-institutional propensity-matched study[J].Lung Cancer2016101:22-27.
9
Pulle MVAsaf BBPuri HV,et al.Meta-Analysis of Limited Thymectomy versus Total Thymectomy for Masaoka Stage I and II Thymoma[J].J Chest Surg202154(2):127-136.
10
Voulaz EVeronesi GInfante M,et al.Radical thymectomy versus conservative thymomectomy in the surgical treatment of thymic malignancies[J].J Thorac Dis201810(7):4127-4136.
11
Papadimas ETan YKLuo H,et al.Partial Versus Complete Thymectomy in Non-Myasthenic Patients With Thymoma: A Systematic Review and Meta-Analysis of Clinical Outcomes[J].Heart Lung Circ202231(1):59-68.
12
Friedant AJHandorf EASu S,et al.Minimally Invasive versus Open Thymectomy for Thymic Malignancies: Systematic Review and Meta-Analysis[J].J Thorac Oncol201611(1):30-38.
13
Guerrera FFalcoz PEMoser B,et al.Thymomectomy plus total thymectomy versus simple thymomectomy for early-stage thymoma without myasthenia gravis: a European Society of Thoracic Surgeons Thymic Working Group Study[J].Eur J Cardiothorac Surg202160(4):881-887.
[1] 禄韶英. 股动脉假性动脉瘤的微创治疗[J]. 中华损伤与修复杂志(电子版), 2023, 18(05): 377-380.
[2] 齐红哲, 彭军, 封国超, 刘光波, 赵宋华, 白克文, 周家宁, 李双成, 周雪峰, 陈华. 将加速康复外科理念应用于跟腱断裂微创治疗的效果观察[J]. 中华损伤与修复杂志(电子版), 2023, 18(03): 217-222.
[3] 王竟楠, 赵吉宏. 从微创到功能:牙槽外科的必由之路[J]. 中华口腔医学研究杂志(电子版), 2023, 17(06): 381-385.
[4] 吴少峰, 张轶男, 孙杰. 机器人辅助手术在儿童微创泌尿手术中的应用和展望[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 440-444.
[5] 刘喆, 黄杰, 胡恩艳, 王祖恒, 傅点, 陈宇豪, 张廷玲, 徐晓峰, 葛京平, 程文. 后腹膜肾上腺肿瘤微创手术的临床研究[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 500-505.
[6] 贺翔, 杨科, 曹义国, 陈贵恒. 腹腔镜治疗小儿鞘膜积液的研究进展[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(05): 526-528.
[7] 李炳根, 龚独辉, 赖泽如, 聂向阳. 产后腹直肌分离全腔镜下肌后/腹膜外补片修补术的临床研究[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 724-727.
[8] 邱朋, 邓正栋, 王剑明. 肝内胆管结石微创治疗策略[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 591-596.
[9] 张天献, 吕云福, 郑进方. 胆总管结石微创治疗进展[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 585-588.
[10] 运陌, 李茂芳, 王浩, 刘东远. 微创穿刺引流联合吡拉西坦、乌拉地尔治疗基底节区高血压性脑出血的临床研究[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(05): 278-285.
[11] 韦维, 李忠华, 黄礼德. 机器人辅助第四脑室血肿穿刺抽吸外引流术[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(04): 255-256.
[12] 谭可, 李锦平, 彭玉涛, 吴文汧, 杨子文, 汪阳, 陶立波, 刘畅. 机器人辅助立体定向血肿引流术治疗自发性脑出血疗效及卫生经济学评价[J]. 中华脑科疾病与康复杂志(电子版), 2023, 13(04): 205-214.
[13] 中华医学会消化内镜学分会. 中国经口胆胰管镜超级微创诊疗技术共识意见(2023年,北京)[J]. 中华胃肠内镜电子杂志, 2023, 10(04): 217-239.
[14] 张波, 姚怡, 张文刚, 柴宁莉, 令狐恩强. 胆道镜直视系统在胆胰"超级微创理念"中的诊疗价值[J]. 中华胃肠内镜电子杂志, 2023, 10(04): 264-266.
[15] 申磊磊, 刘阳. 胸腺瘤的外科治疗:如何选择[J]. 中华胸部外科电子杂志, 2023, 10(04): 224-227.
阅读次数
全文


摘要